{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:12:53Z","timestamp":1793239973315,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The prophylactic action of non-steroidal anti-inflammatory drugs (NSAIDs) in heterotopic ossification (HO) was first described following analgesic therapy with indomethacin. Following that evidence, several compounds have been successfully used for prophylaxes of HO. Ibuprofen has been also proposed for the prevention of HO following THA. The present study compared the administration of ibuprofen for three weeks versus indomethacin as prophylaxis for HO following primary THA. In all THA procedures, pre- and post-operative protocols were conducted in a highly standardized fashion. The type of HO prophylaxis (indomethacin 100\u00a0mg\/daily or ibuprofen 100\u00a0mg\/daily) was chosen according to a chronological criterion: from 2017 to 2019 indomethacin was used, whereas from 2019 to 2022 ibuprofen was administered. In case of allergy or intolerance to NSAIDs, no prophylaxis was performed, and patients were included as a control group. All patients who underwent an anteroposterior radiography of the pelvis at a minimum of 12\u00a0months following THA were considered for inclusion. On admission, the age and sex of the patients were recorded. Moreover, the causes of osteoarthritis and the date of surgery were recorded. The grade of HO was assigned by a blinded assessor who was not involved in the clinical management of the patients. The modified Brooker Staging System was used to rate the efficacy of the interventions. Data from 1248 patients were collected. 62% (767 of 1248 patients) were women. The mean age was 67.0\u2009\u00b1\u20092.9\u00a0years. The mean follow-up was 21.1\u2009\u00b1\u200910.8\u00a0months. In the ibuprofen group, 73% of patients evidenced Brooker 0, 17% Brooker I, and 10% Brooker II. In the indomethacin group, 77% of patients evidenced Brooker 0, 16% Brooker I, 6% Brooker II. No patient in the ibuprofen and indomethacin group developed Brooker III or IV. In the control group, 64% of patients evidenced Brooker 0, 21% Brooker I, 3% Brooker II, and 12% Brooker III. No patient in the control group developed Brooker IV HO. Concluding, three weeks of administration of ibuprofen demonstrated similar efficacy to indomethacin in preventing HO following primary THA. The prophylaxis with ibuprofen or indomethacin was more effective in preventing HO compared to a control group who did not receive any pharmacological prophylaxis.<\/jats:p>","DOI":"10.1038\/s41598-023-47508-8","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:01:51Z","timestamp":1700298111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study"],"prefix":"10.1038","volume":"13","author":[{"given":"Jens","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Maffulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Eschweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7220-1221","authenticated-orcid":false,"given":"Filippo","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"issue":"7","key":"47508_CR1","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00264-018-4124-3","volume":"43","author":"F Migliorini","year":"2019","unstructured":"Migliorini, F. et al. Total hip arthroplasty: Minimally invasive surgery or not? Meta-analysis of clinical trials. Int. Orthop. 43(7), 1573\u20131582. https:\/\/doi.org\/10.1007\/s00264-018-4124-3 (2019).","journal-title":"Int. Orthop."},{"issue":"1","key":"47508_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10195-022-00636-9","volume":"23","author":"F Migliorini","year":"2022","unstructured":"Migliorini, F. et al. Imageless navigation for primary total hip arthroplasty: A meta-analysis study. J. Orthop. Traumatol. 23(1), 21. https:\/\/doi.org\/10.1186\/s10195-022-00636-9 (2022).","journal-title":"J. Orthop. Traumatol."},{"key":"47508_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.surge.2021.07.004","author":"F Migliorini","year":"2021","unstructured":"Migliorini, F., Driessen, A., Eschweiler, J., Tingart, M. & Maffulli, N. No benefits of minimally invasive total hip arthroplasty via Watson-Jones approach: A retrospective cohort study. Surgeon https:\/\/doi.org\/10.1016\/j.surge.2021.07.004 (2021).","journal-title":"Surgeon"},{"issue":"11","key":"47508_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1046\/j.1445-2197.2002.02549.x","volume":"72","author":"B Neal","year":"2002","unstructured":"Neal, B., Gray, H., MacMahon, S. & Dunn, L. Incidence of heterotopic bone formation after major hip surgery. ANZ J. Surg. 72(11), 808\u2013821. https:\/\/doi.org\/10.1046\/j.1445-2197.2002.02549.x (2002).","journal-title":"ANZ J. Surg."},{"issue":"5","key":"47508_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1517\/14656566.9.5.767","volume":"9","author":"RJ Macfarlane","year":"2008","unstructured":"Macfarlane, R. J. et al. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. Expert Opin. Pharmacotherapy 9(5), 767\u2013786. https:\/\/doi.org\/10.1517\/14656566.9.5.767 (2008).","journal-title":"Expert Opin. Pharmacotherapy"},{"issue":"4","key":"47508_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00264-013-1781-0","volume":"37","author":"JJ Brunnekreef","year":"2013","unstructured":"Brunnekreef, J. J., Hoogervorst, P., Ploegmakers, M. J., Rijnen, W. H. & Schreurs, B. W. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?. Int. Orthop. 37(4), 583\u2013587. https:\/\/doi.org\/10.1007\/s00264-013-1781-0 (2013).","journal-title":"Int. Orthop."},{"issue":"6","key":"47508_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1046\/j.1445-2197.2003.02647.x","volume":"73","author":"B Neal","year":"2003","unstructured":"Neal, B. Effects of heterotopic bone formation on outcome after hip arthroplasty. ANZ J. Surg. 73(6), 422\u2013426. https:\/\/doi.org\/10.1046\/j.1445-2197.2003.02647.x (2003).","journal-title":"ANZ J. Surg."},{"key":"47508_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00003086-199102000-00005","volume":"263","author":"L Ahrengart","year":"1991","unstructured":"Ahrengart, L. Periarticular heterotopic ossification after total hip arthroplasty. Risk factors and consequences. Clin. Orthop. Relat. Res. 263, 49\u201358 (1991).","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"8","key":"47508_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00066-005-1352-4","volume":"181","author":"F Pohl","year":"2005","unstructured":"Pohl, F. et al. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty. Strahlentherapie und Onkologie\u202f: Organ der Deutschen Rontgengesellschaft [et al] 181(8), 529\u2013533. https:\/\/doi.org\/10.1007\/s00066-005-1352-4 (2005).","journal-title":"Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]"},{"issue":"1","key":"47508_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/17453678608993206","volume":"57","author":"P Kjaersgaard-Andersen","year":"1986","unstructured":"Kjaersgaard-Andersen, P. & Schmidt, S. A. Indomethacin for prevention of ectopic ossification after hip arthroplasty. Acta Orthop. Scand. 57(1), 12\u201314. https:\/\/doi.org\/10.3109\/17453678608993206 (1986).","journal-title":"Acta Orthop. Scand."},{"issue":"2","key":"47508_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0360-3016(98)00204-1","volume":"42","author":"O K\u00f6lbl","year":"1998","unstructured":"K\u00f6lbl, O. et al. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 42(2), 397\u2013401. https:\/\/doi.org\/10.1016\/s0360-3016(98)00204-1 (1998).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"47508_CR12","unstructured":"Almasbakk, K., Roysland, P. Does indomethacin (IMC) prevent postoperative ectopic ossification in total hip-replacement. In: Acta Orthopaedica Scandinavica, 1977. vol 5. Scandinavian University Press PO BOX 2959 Toyen, Journal Division Customer, pp 556\u2013556"},{"issue":"3","key":"47508_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0883-5403(88)80020-2","volume":"3","author":"JP Cella","year":"1988","unstructured":"Cella, J. P., Salvati, E. A. & Sculco, T. P. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. J. Arthroplasty 3(3), 229\u2013234. https:\/\/doi.org\/10.1016\/s0883-5403(88)80020-2 (1988).","journal-title":"J. Arthroplasty"},{"key":"47508_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00003086-198207000-00015","volume":"167","author":"MA Ritter","year":"1982","unstructured":"Ritter, M. A. & Gioe, T. J. The effect of indomethacin on para-articular ectopic ossification following total hip arthroplasty. Clin. Orthop. Relat. Res. 167, 113\u2013117 (1982).","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"1","key":"47508_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s0883-5403(03)00279-1","volume":"19","author":"CL Roman\u00f2","year":"2004","unstructured":"Roman\u00f2, C. L., Duci, D., Roman\u00f2, D., Mazza, M. & Meani, E. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J. Arthroplasty 19(1), 14\u201318. https:\/\/doi.org\/10.1016\/s0883-5403(03)00279-1 (2004).","journal-title":"J. Arthroplasty"},{"issue":"2","key":"47508_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1302\/0301-620X.89B2.17747","volume":"89","author":"M Saudan","year":"2007","unstructured":"Saudan, M. et al. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: A prospective randomised trial. J. Bone Joint Surg. Br. 89(2), 155\u2013159 (2007).","journal-title":"J. Bone Joint Surg. Br."},{"issue":"5\u20136","key":"47508_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s004020050414","volume":"119","author":"H Kienapfel","year":"1999","unstructured":"Kienapfel, H. et al. Prevention of heterotopic bone formation after total hip arthroplasty: A prospective randomised study comparing postoperative radiation therapy with indomethacin medication. Arch. Orthop. Trauma Surg. 119(5\u20136), 296\u2013302. https:\/\/doi.org\/10.1007\/s004020050414 (1999).","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"1","key":"47508_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00264-009-0886-y","volume":"35","author":"D Xue","year":"2011","unstructured":"Xue, D. et al. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis of randomised trials. Int. Orthop. 35(1), 3\u20138. https:\/\/doi.org\/10.1007\/s00264-009-0886-y (2011).","journal-title":"Int. Orthop."},{"issue":"3","key":"47508_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0167-8140(93)90270-i","volume":"26","author":"MH Seegenschmiedt","year":"1993","unstructured":"Seegenschmiedt, M. H. et al. Prevention of heterotopic ossification (HO) after total hip replacement: Randomized high versus low dose radiotherapy. Radiother. Oncol. 26(3), 271\u2013274. https:\/\/doi.org\/10.1016\/0167-8140(93)90270-i (1993).","journal-title":"Radiother. Oncol."},{"issue":"1","key":"47508_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/17453670610013484","volume":"78","author":"JG Grohs","year":"2007","unstructured":"Grohs, J. G., Schmidt, M. & Wanivenhaus, A. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: A double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop. 78(1), 95\u201398. https:\/\/doi.org\/10.1080\/17453670610013484 (2007).","journal-title":"Acta Orthop."},{"issue":"3","key":"47508_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2106\/00004623-198567030-00008","volume":"67","author":"BJ Thomas","year":"1985","unstructured":"Thomas, B. J. & Amstutz, H. C. Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty. J. Bone Joint Surg. Am. 67(3), 400\u2013403 (1985).","journal-title":"J. Bone Joint Surg. Am."},{"issue":"6","key":"47508_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5435\/00124635-200211000-00005","volume":"10","author":"R Iorio","year":"2002","unstructured":"Iorio, R. & Healy, W. L. Heterotopic ossification after hip and knee arthroplasty: Risk factors, prevention, and treatment. J. Am. Acad. Orthop. Surg. 10(6), 409\u2013416. https:\/\/doi.org\/10.5435\/00124635-200211000-00005 (2002).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"47508_CR23","unstructured":"Lee, A., Amin, N. P. (2020) Radiation Therapy for Heterotopic Ossification Prophylaxis. In: StatPearls. Treasure Island (FL),"},{"issue":"5","key":"47508_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.ijrobp.2006.03.053","volume":"65","author":"TA Balboni","year":"2006","unstructured":"Balboni, T. A., Gobezie, R. & Mamon, H. J. Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int. J. Radiat. Oncol. Biol. Phys. 65(5), 1289\u20131299. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.03.053 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"47508_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10195-022-00646-7","volume":"23","author":"F Migliorini","year":"2022","unstructured":"Migliorini, F. et al. Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: A meta-analysis. J. Orthop. Traumatol. 23(1), 30. https:\/\/doi.org\/10.1186\/s10195-022-00646-7 (2022).","journal-title":"J. Orthop. Traumatol."},{"issue":"2","key":"47508_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.prro.2011.06.005","volume":"2","author":"WF Mourad","year":"2012","unstructured":"Mourad, W. F. et al. Radiation-induced sarcoma following radiation prophylaxis of heterotopic ossification. Pract. Radiat. Oncol. 2(2), 151\u2013154. https:\/\/doi.org\/10.1016\/j.prro.2011.06.005 (2012).","journal-title":"Pract. Radiat. Oncol."},{"key":"47508_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1748-717X-7-140","volume":"7","author":"MK Farris","year":"2012","unstructured":"Farris, M. K., Chowdhry, V. K., Lemke, S., Kilpatrick, M. & Lacombe, M. Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification. Radiat. Oncol. 7, 140. https:\/\/doi.org\/10.1186\/1748-717X-7-140 (2012).","journal-title":"Radiat. Oncol."},{"issue":"18","key":"47508_CR28","doi-asserted-by":"publisher","first-page":"e828","DOI":"10.1097\/md.0000000000000828","volume":"94","author":"S-L Kan","year":"2015","unstructured":"Kan, S.-L. et al. Nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after total hip arthroplasty: A systematic review and meta-analysis. Medicine (Baltimore). 94(18), e828. https:\/\/doi.org\/10.1097\/md.0000000000000828 (2015).","journal-title":"Medicine (Baltimore)."},{"issue":"4","key":"47508_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1302\/0301-620x.79b4.6829","volume":"79","author":"D Knelles","year":"1997","unstructured":"Knelles, D. et al. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J. Bone Joint Surg. Br. 79(4), 596\u2013602. https:\/\/doi.org\/10.1302\/0301-620x.79b4.6829 (1997).","journal-title":"J. Bone Joint Surg. Br."},{"issue":"3","key":"47508_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5301\/hipint.5000109","volume":"24","author":"JK Oni","year":"2014","unstructured":"Oni, J. K., Pinero, J. R., Saltzman, B. M. & Jaffe, F. F. Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study. Hip Int.: J. Clin. Exp. Res. Hip Pathol. Therapy 24(3), 256\u2013262. https:\/\/doi.org\/10.5301\/hipint.5000109 (2014).","journal-title":"Hip Int.: J. Clin. Exp. Res. Hip Pathol. Therapy"},{"issue":"1","key":"47508_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/17453670610013475","volume":"78","author":"HJ van der Heide","year":"2007","unstructured":"van der Heide, H. J., Rijnberg, W. J., Van Sorge, A., Van Kampen, A. & Schreurs, B. W. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty. Acta Orthop. 78(1), 90\u201394. https:\/\/doi.org\/10.1080\/17453670610013475 (2007).","journal-title":"Acta Orthop."},{"key":"47508_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00003086-199912000-00029","volume":"369","author":"C Vielpeau","year":"1999","unstructured":"Vielpeau, C., Joubert, J. M. & Hulet, C. Naproxen in the prevention of heterotopic ossification after total hip replacement. Clin. Orthop. Relat. Res. 369, 279\u2013288. https:\/\/doi.org\/10.1097\/00003086-199912000-00029 (1999).","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"4","key":"47508_CR33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00264-015-3077-z","volume":"40","author":"S Winkler","year":"2016","unstructured":"Winkler, S. et al. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac. Int. Orthop. 40(4), 673\u2013680. https:\/\/doi.org\/10.1007\/s00264-015-3077-z (2016).","journal-title":"Int. Orthop."},{"issue":"2","key":"47508_CR34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00223-020-00763-7","volume":"108","author":"F Migliorini","year":"2021","unstructured":"Migliorini, F. et al. NSAIDs for prophylaxis for heterotopic ossification after total hip arthroplasty: A Bayesian network meta-analysis. Calcif. Tissue Int. 108(2), 196\u2013206. https:\/\/doi.org\/10.1007\/s00223-020-00763-7 (2021).","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"47508_CR35","first-page":"240","volume":"70","author":"HJ van der Heide","year":"2004","unstructured":"van der Heide, H. J., Spruit, M., Slappendel, R., Klooster, N. & van Limbeek, J. Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam. Acta Orthop. Belg. 70(3), 240\u2013246 (2004).","journal-title":"Acta Orthop. Belg."},{"issue":"2","key":"47508_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/17453679408995421","volume":"65","author":"L Ahrengart","year":"1994","unstructured":"Ahrengart, L., Blomgren, G. & Tornkvist, H. Short-term ibuprofen to prevent ossification after hip arthroplasty. No effects in a prospective randomized study of 47 arthrosis cases. Acta Orthop. Scand 65(2), 139\u2013141. https:\/\/doi.org\/10.3109\/17453679408995421 (1994).","journal-title":"Acta Orthop. Scand"},{"issue":"7567","key":"47508_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/bmj.38925.471146.4F","volume":"333","author":"M Fransen","year":"2006","unstructured":"Fransen, M. et al. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): Randomised controlled trial. BMJ 333(7567), 519. https:\/\/doi.org\/10.1136\/bmj.38925.471146.4F (2006).","journal-title":"BMJ"},{"issue":"2","key":"47508_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/17453679809117608","volume":"69","author":"PE Persson","year":"1998","unstructured":"Persson, P. E., Sodemann, B. & Nilsson, O. S. Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time. Acta Orthop. Scand 69(2), 111\u2013115. https:\/\/doi.org\/10.3109\/17453679809117608 (1998).","journal-title":"Acta Orthop. Scand"},{"issue":"1","key":"47508_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/17453678508992973","volume":"56","author":"E Elmstedt","year":"1985","unstructured":"Elmstedt, E., Lindholm, T. S., Nilsson, O. S. & Tornkvist, H. Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop. Scand. 56(1), 25\u201327. https:\/\/doi.org\/10.3109\/17453678508992973 (1985).","journal-title":"Acta Orthop. Scand."},{"issue":"4","key":"47508_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 61(4), 344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008 (2008).","journal-title":"J. Clin. Epidemiol."},{"issue":"8","key":"47508_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/ard.56.8.493","volume":"56","author":"IF Petersson","year":"1997","unstructured":"Petersson, I. F., Boegard, T., Saxne, T., Silman, A. J. & Svensson, B. Radiographic osteoarthritis of the knee classified by the Ahlback and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35\u201354 years with chronic knee pain. Ann. Rheum. Dis. 56(8), 493\u2013496 (1997).","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"47508_CR42","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.2106\/00004623-197355080-00006","volume":"55","author":"AF Brooker","year":"1973","unstructured":"Brooker, A. F., Bowerman, J. W., Robinson, R. A. & Riley, L. H. Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J. Bone Joint Surg. Am. 55(8), 1629\u20131632 (1973).","journal-title":"J. Bone Joint Surg. Am."},{"key":"47508_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/01.blo.0000150294.81825.8c","volume":"429","author":"KC Bertin","year":"2004","unstructured":"Bertin, K. C. & Rottinger, H. Anterolateral mini-incision hip replacement surgery: A modified Watson\u2013Jones approach. Clin. Orthop. Relat. Res. 429, 248\u2013255 (2004).","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"47508_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/17453679809117607","volume":"69","author":"U Dorn","year":"1998","unstructured":"Dorn, U. et al. Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment. Acta Orthop. Scand 69(2), 107\u2013110. https:\/\/doi.org\/10.3109\/17453679809117607 (1998).","journal-title":"Acta Orthop. Scand"},{"issue":"3","key":"47508_CR45","first-page":"205","volume":"61","author":"A Burssens","year":"1995","unstructured":"Burssens, A., Thiery, J., Kohl, P., Molderez, A. & Haazen, L. Prevention of heterotopic ossification with tenoxicam following total hip arthroplasty: A double-blind, placebo-controlled dose-finding study. Acta Orthop. Belg. 61(3), 205\u2013211 (1995).","journal-title":"Acta Orthop. Belg."},{"issue":"6","key":"47508_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3109\/17453679308994587","volume":"64","author":"P Kjaersgaard-Andersen","year":"1993","unstructured":"Kjaersgaard-Andersen, P. et al. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Acta Orthop. Scand. 64(6), 639\u2013642. https:\/\/doi.org\/10.3109\/17453679308994587 (1993).","journal-title":"Acta Orthop. Scand."},{"issue":"4","key":"47508_CR47","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1302\/0301-620x.79b4.6829","volume":"79","author":"D Knelles","year":"1997","unstructured":"Knelles, D. et al. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J. Bone Joint Surg. Br. 79(4), 596\u2013602. https:\/\/doi.org\/10.1302\/0301-620x.79b4.6829 (1997).","journal-title":"J. Bone Joint Surg. Br."},{"issue":"2\u20133","key":"47508_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00402-003-0487-y","volume":"123","author":"R Legenstein","year":"2003","unstructured":"Legenstein, R., Bosch, P. & Ungersbock, A. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty. Arch. Orthop. Trauma Surg. 123(2\u20133), 91\u201394. https:\/\/doi.org\/10.1007\/s00402-003-0487-y (2003).","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"1","key":"47508_CR49","doi-asserted-by":"publisher","first-page":"e12759","DOI":"10.7759\/cureus.12759","volume":"13","author":"M Yibirin","year":"2021","unstructured":"Yibirin, M., De Oliveira, D., Valera, R., Plitt, A. E. & Lutgen, S. Adverse effects associated with proton pump inhibitor use. Cureus 13(1), e12759. https:\/\/doi.org\/10.7759\/cureus.12759 (2021).","journal-title":"Cureus"},{"key":"47508_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205203","author":"R Fossmark","year":"2019","unstructured":"Fossmark, R., Martinsen, T. C. & Waldum, H. L. Adverse effects of proton pump inhibitors-evidence and plausibility. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20205203 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"47508_CR51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/JPR.S156938","volume":"11","author":"KA Gwee","year":"2018","unstructured":"Gwee, K. A., Goh, V., Lima, G. & Setia, S. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: Risks versus benefits. J. Pain Res. 11, 361\u2013374. https:\/\/doi.org\/10.2147\/JPR.S156938 (2018).","journal-title":"J. Pain Res."},{"issue":"8","key":"47508_CR52","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/j.1572-0241.2006.00686.x","volume":"101","author":"J Regula","year":"2006","unstructured":"Regula, J. et al. Prevention of NSAID-associated gastrointestinal lesions: A comparison study pantoprazole versus omeprazole. Am. J. Gastroenterol. 101(8), 1747\u20131755. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00686.x (2006).","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"47508_CR53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0031-1296397","volume":"59","author":"U Klotz","year":"2009","unstructured":"Klotz, U. Proton pump inhibitors\u2014Their pharmacological impact on the clinical management of acid-related disorders. Arzneimittelforschung 59(6), 271\u2013282. https:\/\/doi.org\/10.1055\/s-0031-1296397 (2009).","journal-title":"Arzneimittelforschung"},{"issue":"Suppl 2","key":"47508_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/1153121-S0-000000000-00000","volume":"29","author":"L Moreira Dias","year":"2009","unstructured":"Moreira Dias, L. Pantoprazole: A proton pump inhibitor. Clin. Drug Investig. 29(Suppl 2), 3\u201312. https:\/\/doi.org\/10.2165\/1153121-S0-000000000-00000 (2009).","journal-title":"Clin. Drug Investig."},{"issue":"1","key":"47508_CR55","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00003495-200363010-00006","volume":"63","author":"SM Cheer","year":"2003","unstructured":"Cheer, S. M., Prakash, A., Faulds, D. & Lamb, H. M. Pantoprazole: An update of its pharmacological properties and therapeutic use in the management of acid-related disorders. Drugs 63(1), 101\u2013133. https:\/\/doi.org\/10.2165\/00003495-200363010-00006 (2003).","journal-title":"Drugs"},{"issue":"12","key":"47508_CR56","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2165\/00003495-200161120-00011","volume":"61","author":"AJ Matheson","year":"2001","unstructured":"Matheson, A. J. & Jarvis, B. Lansoprazole: An update of its place in the management of acid-related disorders. Drugs 61(12), 1801\u20131833. https:\/\/doi.org\/10.2165\/00003495-200161120-00011 (2001).","journal-title":"Drugs"},{"issue":"Suppl 3","key":"47508_CR57","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/ar4177","volume":"15","author":"JM Scheiman","year":"2013","unstructured":"Scheiman, J. M. The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthritis Res. Ther. 15(Suppl 3), S5. https:\/\/doi.org\/10.1186\/ar4177 (2013).","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"47508_CR58","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s12891-020-03670-y","volume":"21","author":"C Rimke","year":"2020","unstructured":"Rimke, C. et al. Evaluation of the standard procedure for the treatment of periprosthetic joint infections (PJI) in Germany - results of a survey within the EndoCert initiative. BMC Musculoskelet Disord. 21(1), 694. https:\/\/doi.org\/10.1186\/s12891-020-03670-y (2020).","journal-title":"BMC Musculoskelet Disord."},{"issue":"1","key":"47508_CR59","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12891-021-04661-3","volume":"22","author":"K Osmanski-Zenk","year":"2021","unstructured":"Osmanski-Zenk, K. et al. Evaluation of the standard procedure for treatment of periprosthetic joint infections of total knee and hip arthroplasty: a comparison of the 2015 and 2020 census in total joint replacement centres in Germany. BMC Musculoskelet Disord. 22(1), 791. https:\/\/doi.org\/10.1186\/s12891-021-04661-3 (2021).","journal-title":"BMC Musculoskelet Disord."},{"key":"47508_CR60","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1136\/ard.2003.016477","volume":"63","author":"M Reijman","year":"2004","unstructured":"Reijman, M., Hazes, J. M. W. & Pols, H. A. P. Validity and reliability of three definitions of hip osteoarthritis: Cross sectional and longitudinal approach. Ann. Rheumatic Dis. 63, 1427\u20131433 (2004).","journal-title":"Ann. Rheumatic Dis."},{"issue":"2","key":"47508_CR61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/joca.1998.0152","volume":"7","author":"KP Gunther","year":"1999","unstructured":"Gunther, K. P. & Sun, Y. Reliability of radiographic assessment in hip and knee osteoarthritis. Osteoarthritis Cartilage 7(2), 239\u2013246. https:\/\/doi.org\/10.1053\/joca.1998.0152 (1999).","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"47508_CR62","first-page":"37","volume":"66","author":"SP Karande","year":"2018","unstructured":"Karande, S. P. & Kini, S. Osteoarthritis: Clinical and radiological correlation. J. Assoc. Physicians India 66(7), 37\u201339 (2018).","journal-title":"J. Assoc. Physicians India"},{"issue":"Suppl","key":"47508_CR63","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/s0883-5403(08)80024-1","volume":"5","author":"PR Rockwood","year":"1990","unstructured":"Rockwood, P. R. & Horne, J. G. Heterotopic ossification following uncemented total hip arthroplasty. J. Arthroplasty 5(Suppl), S43-46. https:\/\/doi.org\/10.1016\/s0883-5403(08)80024-1 (1990).","journal-title":"J. Arthroplasty"},{"issue":"Suppl 2","key":"47508_CR64","first-page":"43","volume":"61","author":"M Postel","year":"1975","unstructured":"Postel, M. Ossification. Rev. Chir. Orthop. Reparatrice Appar. Mot. 61(Suppl 2), 43\u201346 (1975).","journal-title":"Rev. Chir. Orthop. Reparatrice Appar. Mot."},{"issue":"7","key":"47508_CR65","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00402-021-03783-6","volume":"141","author":"JHJ van Erp","year":"2021","unstructured":"van Erp, J. H. J. et al. Heterotopic ossification in primary total hip arthroplasty using the posterolateral compared to the direct lateral approach. Arch. Orthop. Trauma Surg. 141(7), 1253\u20131259. https:\/\/doi.org\/10.1007\/s00402-021-03783-6 (2021).","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"47508_CR66","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00003086-198409000-00020","volume":"188","author":"BF Morrey","year":"1984","unstructured":"Morrey, B. F., Adams, R. A. & Cabanela, M. E. Comparison of heterotopic bone after anterolateral, transtrochanteric, and posterior approaches for total hip arthroplasty. Clin. Orthop. Relat. Res. 188, 160\u2013167 (1984).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"47508_CR67","doi-asserted-by":"publisher","DOI":"10.1177\/1120700020970793","author":"N Zran","year":"2020","unstructured":"Zran, N., Joseph, E., Callamand, G., Ohl, X. & Siboni, R. Heterotopic ossification after total hip arthroplasty: Radiological comparison between a direct anterior approach without an orthopaedic table and a posterior approach. Hip Int. https:\/\/doi.org\/10.1177\/1120700020970793 (2020).","journal-title":"Hip Int."},{"issue":"4","key":"47508_CR68","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.arth.2016.11.030","volume":"32","author":"P Alijanipour","year":"2017","unstructured":"Alijanipour, P., Patel, R. P., Naik, T. U. & Parvizi, J. Heterotopic ossification in primary total hip arthroplasty using the direct anterior vs direct lateral approach. J. Arthroplasty 32(4), 1323\u20131327. https:\/\/doi.org\/10.1016\/j.arth.2016.11.030 (2017).","journal-title":"J. Arthroplasty"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47508-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47508-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47508-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:23:34Z","timestamp":1700299414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47508-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47508"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47508-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,18]]},"assertion":[{"value":"25 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20210"}}